| EARNINGS (LOSS) PER SHARE |
NOTE 23: EARNINGS (LOSS) PER SHARE
The following table presents the computation of basic and diluted earnings (loss) per share (“EPS”):
| |
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
| |
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
Basic EPS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
(1,205,321
|
)
|
|
$
|
(61,176
|
)
|
|
$
|
(1,493,450
|
)
|
|
$
|
196,712
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in computing net earnings (loss) per share of common stock, basic
|
|
|
57,029,983
|
|
|
|
56,671,504
|
|
|
|
56,952,656
|
|
|
|
56,435,880
|
|
|
Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to common stock, basic
|
|
$
|
(1,205,321
|
)
|
|
$
|
(61,176
|
)
|
|
$
|
(1,493,450
|
)
|
|
$
|
196,712
|
|
|
Notes 2025
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,608
|
|
|
Net income (loss) attributable to common stock, diluted
|
|
$
|
(1,205,321
|
)
|
|
$
|
(61,176
|
)
|
|
$
|
(1,493,450
|
)
|
|
$
|
198,320
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in computing net earnings (loss) per share of common stock, basic
|
|
|
57,029,983
|
|
|
|
56,671,504
|
|
|
|
56,952,656
|
|
|
|
56,435,880
|
|
|
Notes 2025
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,276,818
|
|
|
Effect of stock-based awards
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
584,725
|
|
|
Shares used in computing net earnings (loss) per share of common stock, diluted
|
|
|
57,029,983
|
|
|
|
56,671,504
|
|
|
|
56,952,656
|
|
|
|
59,297,423
|
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(21.13
|
)
|
|
$
|
(1.08
|
)
|
|
$
|
(26.22
|
)
|
|
$
|
3.49
|
|
|
Diluted
|
|
$
|
(21.13
|
)
|
|
$
|
(1.08
|
)
|
|
$
|
(26.22
|
)
|
|
$
|
3.34
|
|
The following outstanding shares of common stock equivalents were excluded from the calculation due to their antidilutive nature:
| |
|
Three Months Ended
September 30,
|
|
|
Nine Months Ended
September 30,
|
|
| |
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
|
Stock-based awards
|
|
|
2,552,867
|
|
|
|
1,072,938
|
|
|
|
2,055,632
|
|
|
|
-
|
|
|
Notes 2025
|
|
|
-
|
|
|
|
2,276,818
|
|
|
|
1,510,363
|
|
|
|
-
|
|
|
Notes 20291
|
|
|
984,342
|
|
|
|
-
|
|
|
|
392,152
|
|
|
|
-
|
|
|
Total shares excluded
|
|
|
3,537,209
|
|
|
|
3,349,756
|
|
|
|
3,958,147
|
|
|
|
-
|
|
1 In conjunction with the issuance of the Notes 2029 in June 2024, the Company used approximately $25,230 of the net proceeds from this offering to pay the cost of the capped call transactions. In July 2024, following an additional issuance of the Notes 2029, $3,111 of net proceeds were used to pay the cost of capped call transactions. In accordance with FASB ASC 260, antidilutive contracts, such as purchased call options are excluded from the computation of diluted net income (loss) per share. Accordingly, any potential impact resulting from capped call transaction is excluded from our computation of diluted net income (loss) per share.
|